Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

4.030 -0.010 (-0.25%)
Streaming Delayed Price Updated: 9:48 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Anavex Life Sciences Stock Shows Improved Price Strength Rating ↗
Anavex Life Sciences stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75. 
Via Investor's Business Daily
News headline image
Earnings Preview: Anavex Life Sciences ↗
 
Via Benzinga
News headline image
3 Biotech Stocks Under $15 Worth a Second Look in 2023 ↗
All three stocks have promising therapies that could drive revenue in the coming years. 
Via The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today ↗
 
Via Benzinga
News headline image
Top Picks For 2023: Anavex Life Sciences ↗
Anavex is a biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system diseases, with encouraging results in Alzheimer’s, Parkinson’s, and Rett... 
Via Talk Markets
News headline image
Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday ↗
Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market... 
Via Benzinga
Here's How Much $100 Invested In Anavex Life Sciences 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Anavex Life Sciences Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Anavex Catapults On Alzheimer's Results — But Math Question Clouds The Data ↗
A math error could have clouded the drug's actual benefits. 
Via Investor's Business Daily
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,500 Today ↗
 
Via Benzinga
News headline image
Analyzing Anavex Life Sciences's Short Interest ↗
Anavex Life Sciences's (NASDAQ:AVXL) short percent of float has risen 17.06% since its last report. The company recently reported that it has 11.91 million shares sold short, which is 15.71% of all... 
Via Benzinga
News headline image
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why ↗
The biotech will first need to assuage the concerns of experts by elaborating on its latest clinical trial data. 
Via The Motley Fool
News headline image
Is Anavex Life Sciences a Buy? ↗
It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's. 
Via The Motley Fool
News headline image
Is Anavex Life Sciences a Smart Stock to Buy Now? ↗
The company's Alzheimer's disease drug just succeeded in a clinical trial. Or did it? 
Via The Motley Fool
News headline image
Dow Drops 100 Points; Asana Shares Plummet ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday. 
Via Benzinga
News headline image
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Gold Down 1%; Samsara Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday. 
Via Benzinga
News headline image
Why Anavex Life Sciences Stock Is Surging Today ↗
The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate. 
Via The Motley Fool
News headline image
Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News ↗
Rigel Pharmaceuticals (RIGL) stock is heading higher on Friday after getting approval from the FDA for its leukemia treatment. 
Via InvestorPlace
News headline image
Why Is Anavex Life Sciences (AVXL) Stock Up 30% Today? ↗
Anavex Life Sciences (AVXL) stock is rocketing higher on Friday following positive results from an Alzheimer’s clinical trial. 
Via InvestorPlace
News headline image
Smartsheet, Samsara, Anavex Life Sciences And Some Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded mostly lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Dow Tumbles 300 Points After US Economy Adds 263,000 Jobs ↗
U.S. stocks traded lower this morning, with the Dow Jones falling more than 300 points on Friday following the release of jobs data for November. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Jim Cramer Says This Stock Is Dynamite: 'I Do Not Want You To Do A Thing Other Than Ride It' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Williams Companies, Inc. (NYSE: WMB) is "terrific." He recommended buying the stock. 
Via Benzinga
News headline image
Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today ↗
Major Wall Street indices closed over 1% lower on Monday after protests in China against COVID-zero policies led to supply chain concerns. 
Via Benzinga
News headline image
Why Shares of Anavex Life Sciences Slumped 23.5% on Monday ↗
The company released its fourth-quarter and full-year numbers. 
Via The Motley Fool
News headline image
Dow Tumbles 450 Points; S&P 500 Falls 1.5% ↗
U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday. 
Via Benzinga
News headline image
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.